Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, we have witnessed profound health inequities suffered by Black, Indigenous, and People of Color (BIPOC). These manifested as differential access to testing early in the pandemic, rates of severe disease and death 2–3 times higher than white Americans, and, now, significantly lower vaccine uptake compared with their share of the population affected by COVID-19. This article explores the impact of these COVID-19 inequities (and the underlying cause, structural racism) on vaccine acceptance in BIPOC populations, ways to establish trustworthiness of healthcare institutions, increase vaccine access for BIPOC communities, and inspire confidence in COVID-19 vaccines.

Details

Title
Addressing and Inspiring Vaccine Confidence in Black, Indigenous, and People of Color During the Coronavirus Disease 2019 Pandemic
Author
Marcelin, Jasmine R 1   VIAFID ORCID Logo  ; Swartz, Talia H 2 ; Fidelia Bernice 3 ; Berthaud, Vladimir 4   VIAFID ORCID Logo  ; Robbie, Christian 5 ; da Costa, Christopher 6 ; Fadul, Nada 1 ; Floris-Moore, Michelle 7 ; Hlatshwayo, Matifadza 8 ; Johansson, Patrik 9 ; Ravina Kullar 10 ; Manning, Kimberly 11 ; McGee, Edoabasi U 12   VIAFID ORCID Logo  ; Medlin, Christopher 13 ; Piggott, Damani A 14 ; Syed, Uzma 15 ; Snowden, Jessica 16 ; Tan, Tina 17 ; Abdul-Mutakabbir, Jacinda C 18 

1  Division of Infectious Diseases, University of Nebraska Medical Center, Omaha Nebraska, USA 
2  Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA 
3  Department of Pharmacy, University of Maryland Medical Center, Baltimore, Maryland, USA 
4  Division of Infectious Diseases, Meharry Medical College, Nashville, Tennessee, USA 
5  Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, USA 
6  The Coalition for Epidemic Preparedness Innovations, Washington, District of Columbia, USA 
7  Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA 
8  Division of Infectious Diseases, John Cochrane VA Medical Center, St. Louis, Missouri, USA 
9  Department of Medical Education and Clinical Sciences, Washington State University, Seattle, Washington, USA 
10  Expert Stewardship Inc., Newport Beach, California, USA 
11  Division of General Medicine, Emory University School of Medicine, Atlanta, Georgia, USA 
12  Philadelphia College of Osteopathic Medicine, School of Pharmacy, Suwanee, Georgia, USA 
13  University of Texas at El Paso School of Pharmacy, El Paso, Texas, USA 
14  Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 
15  South Shore Infectious Disease & Travel Medicine Consultants, P.C., Bay Shore, New York, USA 
16  Division of Pediatric Infectious Disease, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA 
17  Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA 
18  Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, California, USA 
Publication year
2021
Publication date
Sep 2021
Publisher
Oxford University Press
e-ISSN
23288957
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1093/ofid/ofab417
ProQuest document ID
3171173872
Copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.